2026 NPPES data Medical Oncology Physician NPI 1871844258 MBBS
Verify on CMS →

MAKARDHWAJ SHRIVASTAVA, MBBS

Medical Oncology Physician in PHOENIX, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
214
Medicare Part D claims · 47 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
71%
generic claims · 29% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MAKARDHWAJ SHRIVASTAVA, MBBS filed 214 Medicare Part D claims in 2023 as a Medical Oncology Physician in PHOENIX, Arizona, prescribing 71% generic.

214
Part D claims, 2023
71%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MAKARDHWAJ SHRIVASTAVA, MBBS's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

214 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MAKARDHWAJ SHRIVASTAVA, MBBS practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MAKARDHWAJ SHRIVASTAVA, MBBS?

Quality data not reported

NPI registry status

Active

Issued 09/26/2012

NPI 1871844258

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

214 69% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Arizona

How Medical Oncology Physician compares to other specialties among Arizona providers

Arizona providers

Medical Oncology Physician share within Arizona

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Arizona

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MAKARDHWAJ SHRIVASTAVA, MBBS appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MBBS credentials at 625 N 6TH ST, PHOENIX, AZ, 85004, with a listed phone of (602) 406-8222. NPI 1871844258 was issued on 09/26/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHRIVASTAVA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 214 prescription claims written by this provider, covering 47 Medicare beneficiaries and totaling roughly $608K in drug spend, split 29% brand-name and 71% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

625 N 6TH ST
PHOENIX, AZ 85004

Provider Details

NPI 1871844258
Specialty Medical Oncology Physician
Credentials MBBS
Gender Male
NPI Issued 09/26/2012

Hospital and facility affiliations

Facilities where MAKARDHWAJ SHRIVASTAVA, MBBS bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SJHMC PHYSICIAN SERVICES
PHOENIX, AZ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

MAKARDHWAJ SHRIVASTAVA, MBBS — brand share 29.0%
Specialty average (est.)

29% brand-name claims vs 71% generic, on 214 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

214
Total Claims
$608K
Total Drug Cost
47
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
318
Total Day Supply
8,239
Brand vs Generic
29% brand / 71% generic
Brand Drug Cost
$589K
Generic Drug Cost
$19K

Patient Demographics

Average Patient Age
71.2 years
Avg HCC Risk Score
2.05
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MAKARDHWAJ SHRIVASTAVA, MBBS prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
22
Ondansetron Odt
Ondansetron
17
Eliquis
Apixaban
16
Prochlorperazine Maleate
16
Ibrance
Palbociclib
15
Anastrozole
14
Exemestane
13
Loperamide
Loperamide Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How MAKARDHWAJ SHRIVASTAVA, MBBS fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

MAKARDHWAJ SHRIVASTAVA, MBBS's 214 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Arizona

Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as SHRIVASTAVA.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MAKARDHWAJ SHRIVASTAVA, MBBS's specialty?
MAKARDHWAJ SHRIVASTAVA, MBBS specializes in Medical Oncology Physician and practices in PHOENIX, Arizona. Credentials: MBBS.
How much does MAKARDHWAJ SHRIVASTAVA, MBBS prescribe under Medicare Part D?
In 2023, MAKARDHWAJ SHRIVASTAVA, MBBS wrote 214 Medicare Part D claims totaling $608K in drug costs for 47 beneficiaries.
Where is MAKARDHWAJ SHRIVASTAVA, MBBS located?
MAKARDHWAJ SHRIVASTAVA, MBBS is located at 625 N 6TH ST, PHOENIX, AZ, 85004. Phone: (602) 406-8222.
What is MAKARDHWAJ SHRIVASTAVA, MBBS's NPI number?
MAKARDHWAJ SHRIVASTAVA, MBBS's National Provider Identifier (NPI) is 1871844258, issued on 09/26/2012.
Does MAKARDHWAJ SHRIVASTAVA, MBBS prescribe more brand-name or generic drugs?
MAKARDHWAJ SHRIVASTAVA, MBBS's prescribing is 29% brand-name and 71% generic drugs by claim count, with $589K in brand drug costs.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does MAKARDHWAJ SHRIVASTAVA, MBBS prescribe most often?
Based on 2023 Medicare Part D data, MAKARDHWAJ SHRIVASTAVA, MBBS's most frequently prescribed drugs include Letrozole, Ondansetron Odt, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MAKARDHWAJ SHRIVASTAVA, MBBS accept Medicare?
MAKARDHWAJ SHRIVASTAVA, MBBS appears in CMS Medicare data with 214 Part D claims and 47 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MAKARDHWAJ SHRIVASTAVA, MBBS's credentials?
MAKARDHWAJ SHRIVASTAVA, MBBS's NPI is 1871844258 with credentials MBBS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology